CPHRF.US Cipher Pharmaceuticals Inc

Healthcare Pharmaceuticals USA Stocks
9.94 USD
Close of Nov 14, 2026
9.27 15.00
Market cap
USD 253M
P/E
9.0x
P/B
1.77x
ROE
14.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CPHRF.US undervalued?

Graham number
Price9.94
Graham value11.85
Discount16.1%

CPHRF.US trades 16.1% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cipher Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Cipher Pharmaceuticals Inc yet.

Cipher Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cipher Pharmaceuticals Inc

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Vaniqa, a topical cream for the slowing of the growth of un…

Full company profile